PREDNISOLONE , Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab
R668-BP-1902
Phase 3 small_molecule active
Quick answer
PREDNISOLONE , Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab for Bullous Pemphigoid is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Bullous Pemphigoid
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active